Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis

Journal of Thrombosis and Haemostasis

Volumn 14, Issue 5, 2016, Pages 973-981

  Bleker, S M ^a   van Es, N ^a   Kleinjan, A ^a   Buller H R ^a   Kamphuisen, P W ^b   Aggarwal, A ^c   Beyer Westendorf, J ^d   Camporese, G ^e   Cosmi, B ^f   Gary, T ^g   Ghirarduzzi, A ^h   Kaasjager, K ⁱ   Lerede, T ^j   Marschang, P ^k   Meijer, K ^b   Otten, H M ^l   Porreca, E ^m   Righini, M ⁿ   Verhamme, P ^o   van Wissen, S ^p   Di Nisio, M ^a,m   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h Company Institute for Hospitalization and Care Scientific Arcispedale Santa Maria Nova ^*  (Italy)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

^k INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^l SLOTERVAART HOSPITAL   (Netherlands)

^m UNIVERSITY OF CHIETI   (Italy)

ⁿ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^o UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^p ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

more..

Author keywords

Hemorrhage; Mortality; Neoplasms; Recurrence; Therapy; Upper extremity deep vein thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; ARTICLE; BLEEDING; CLINICAL EFFECTIVENESS; COMPRESSION STOCKING; COMPRESSION THERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MIDDLE AGED; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT DURATION; UPPER EXTREMITY DEEP VEIN THROMBOSIS; UPPER EXTREMITY SUPERFICIAL VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; AGED; CLINICAL DECISION SUPPORT SYSTEM; COMPLICATION; FOLLOW UP; NEOPLASM; PREVALENCE; RISK FACTOR; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADULT; AGED; ANTICOAGULANTS; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84962739455     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13291     Document Type: Article

References (29)

1. Mai C, Hunt D. Upper-extremity deep venous thrombosis: a review. Am J Med 2011; 124: 402-7.
2. Isma N, Svensson PJ, Gottsäter A, Lindblad B. Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality. Thromb Res 2010; 125: e335-8.
3. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110: 1605-11.
4. Muñoz FJ, Mismetti P, Poggio R, Valle R, Barrón M, Guil M, Monreal M. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008; 133: 143-8.
5. Bernardi E, Pesavento R, Prandoni P. Upper extremity deep venous thrombosis. Semin Thromb Hemost 2006; 32: 729-36.
6. Flinterman LE, Van Hylckama Vlieg A, Rosendaal FR, Doggen CJM. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation 2008; 118: 1366-72.
7. Prandoni P, Bernardi E, Marchiori A, Lensing AWA, Prins MH, Villalta S, Bagatella P, Sartor D, Piccioli A, Simioni P, Pagnan A, Girolami A. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ 2004; 329: 484-5.
8. Savage KJ, Wells PS, Schulz V, Goudie D, Morrow B, Cruickshank M, Kovacs MJ. Outpatient use of low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb Haemost 1999; 82: 1008-10.
9. Lee WA, Hill BB, Harris EJ, Semba CP, Olcott C. Surgical intervention is not required for all patients with subclavian vein thrombosis. J Vasc Surg 2000; 32: 57-67.
10. Lee AYY, Levine MN, Butler G, Webb C, Costantini L, Gu C, Julian JA. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006; 24: 1404-8.
11. Kovacs MJ, Kahn SR, Rodger M, Anderson DR, Andreou R, Mangel JE, Morrow B, Clement AM, Wells PS. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007; 5: 1650-3.
12. Lechner D, Wiener C, Weltermann A, Eischer L, Eichinger S, Kyrle PA. Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost 2008; 6: 1269-74.
13. Rathbun SW, Stoner JA, Whitsett TL. Treatment of upper-extremity deep vein thrombosis. J Thromb Haemost 2011; 9: 1924-30.
14. Baumann Kreuziger L, Cote L, Verhamme P, Greenberg S, Caprini J, Muñoz F, Valle R, Monreal Bosch M. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis. J Vasc Surg Venous Lym Dis 2015; 3: 243-50.
15. Kleinjan A, Di Nisio M, Beyer-Westendorf J, Camporese G, Cosmi B, Ghirarduzzi A, Kamphuisen PW, Otten H-M, Porreca E, Aggarwal A, Brodmann M, Guglielmi MD, Iotti M, Kaasjager K, Kamvissi V, Lerede T, Marschang P, Meijer K, Palareti G, Rickles FR, et al. Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med 2014; 160: 451-7.
16. Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C. Definition of postthrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 2009; 7: 879-83.
17. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-4.
18. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e419S-94S.
19. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362: 523-6.
20. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160: 761-8.
21. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1, 626 patients. Haematologica 2007; 92: 199-205.
22. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160: 769-74.
23. Elman EE, Kahn SR. The postthrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res 2006; 117: 609-14.
24. Prandoni P, Lensing AWA, Prins MH, Frulla M, Marchiori A, Bernardi E, Tormene D, Mosena L, Pagnan A, Girolami A. Below-knee elastic compression stockings to prevent the postthrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141: 249-56.
25. Brandjes DP, Büller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-62.
26. Prandoni P, Lensing AWA, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-8.
27. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JGP, Büller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved International Normalized Ratio: a retrospective analysis. J Clin Oncol 2000; 18: 3078-83.
28. Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-50.
29. Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS. Development and validation of a tool for patient reporting of symptoms and signs of the postthrombotic syndrome. Thromb Haemost 2015; 115: 361-7.